medvi glp-1 Matthew Gallagher founded Medvi, a telehealth platform for weight-loss drugs, with a $20,000 investment. ⁠ ⁠ Operating from a home in Los Angeles, he scaled the business using a "staff" of 🤖 ONE MAN. $20K. BILLION-DOLLAR

Choose PT-141 if: Sexual function is your only goal desire, arousal, or ED Safety matters you want an FDA-approved, clinically tested peptide You want on-demand use take it only when needed You don't want tanning PT-141 won't change your skin color Nausea is a concern PT-141's nausea profile is significantly milder You have mole concerns PT-141 doesn't affect melanocytes Choose MT-2 if: You want tanning as the primary goal with sexual effects as a bonus You want both tanning AND sexual enhancement MT-2 delivers both Cost is a priority MT-2 is generally cheaper per vial You're comfortable with unregulated products and accept the additional risk You've had a dermatological baseline and will monitor moles regularly Consider Neither if: You have melanoma history avoid MT-2

2022;39 doi: 10.1111/dme.14681

10.1016/j.jplph.2014.03.002 11 GillS

PS, propensity score

Arab J Chem2024 May, 17, 5, 105745